Q. Liu
Construction of a doxycycline inducible adipogenic lentiviral expression system
Liu, Q.; Hill, P.J.; Karamitri, Angeliki; Ryan, K.J.P.; Chen, H.Y.; Lomax, Michael A.
Authors
P.J. Hill
Angeliki Karamitri
K.J.P. Ryan
H.Y. Chen
Michael A. Lomax
Abstract
To provide a tool for research on regulating adipocyte differentiation, tetracycline inducible (Tet on) lentiviral expression vectors under the control of an adipose-specific promoter were constructed. The lowest basal expression in the absence of doxycycline and most efficient dose-dependent, doxycycline-induced transient overexpression was observed using vectors constructed with a combination of Tetracycline Responsive Element (TRE) and reverse tetracycline-controlled TransActivator advanced (rtTAadv), transfected in white (3T3-L1) and brown (HIB-1B) preadipocytes cell lines. The results demonstrate that doxycycline adipogenic inducible expression can be achieved using a pLenti TRE / rtTA adv under the control of the truncated aP2 promoter in HIB-1B preadipocytes.
Citation
Liu, Q., Hill, P., Karamitri, A., Ryan, K., Chen, H., & Lomax, M. A. (2013). Construction of a doxycycline inducible adipogenic lentiviral expression system. Plasmid, 69(1), https://doi.org/10.1016/j.plasmid.2012.10.001
Journal Article Type | Article |
---|---|
Publication Date | Jan 1, 2013 |
Deposit Date | May 14, 2014 |
Publicly Available Date | May 14, 2014 |
Journal | Plasmid |
Print ISSN | 0147-619X |
Electronic ISSN | 0147-619X |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 69 |
Issue | 1 |
DOI | https://doi.org/10.1016/j.plasmid.2012.10.001 |
Keywords | Tetracycline inducible expression; Lentiviral plasmid; Adipose-specific promoter; Adipocyte |
Public URL | https://nottingham-repository.worktribe.com/output/1003064 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0147619X12001060 |
Files
Lomax_Construction_of_a_doxycycline_inducible_adipogenic_lentiviral.pdf
(663 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0